| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/19/1997 | EP0758377A1 Alkaline glucose oxidase |
| 02/19/1997 | EP0758373A1 Fabric cleaning compositions containing subtilisin bpn' variants |
| 02/19/1997 | EP0758250A1 Texaphyrin solid-supports and devices |
| 02/19/1997 | EP0758242A1 Composition and method for treatment of cmv infection |
| 02/19/1997 | EP0730568A4 Amphiphilic derivatives of piperazine |
| 02/19/1997 | EP0730405A4 Amphiphilic derivatives of guanidine |
| 02/19/1997 | EP0730404A4 Amphiphilic imidazolinium derivatives |
| 02/19/1997 | CN1143390A Method of synthesizing fluorescently labeled protein |
| 02/19/1997 | CN1143387A Thermostable xylanases |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143374A Non-viral vector |
| 02/19/1997 | CN1143373A 乙型肝炎疫苗 Hepatitis B Vaccine |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1143325A Method for selective methionine starvation of malignant cells in mammals |
| 02/19/1997 | CN1143116A New human erythropoietin |
| 02/19/1997 | CN1143115A Method for producing 3-methyl-7-alkyl-yellow purine micro-organism |
| 02/19/1997 | CN1143113A Transgene plant of pod specific express toxoprotein |
| 02/19/1997 | CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases |
| 02/19/1997 | CN1034084C Compact detergent composition with high activity cellulase |
| 02/19/1997 | CN1034080C Preparing method for insulin analogs |
| 02/19/1997 | CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region |
| 02/19/1997 | CA2183196A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use |
| 02/18/1997 | US5604293 Wound healing and tissue repair |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/18/1997 | US5604131 cDNA-genomic DNA hybrid sequence encoding APP770 containing a genomic DNA insert of the KI and OX-2 regions |
| 02/18/1997 | US5604129 Thermophilic fungal expression system |
| 02/18/1997 | US5604122 Improvements in or relating to DNA cloning techniques and products for use therewith |
| 02/18/1997 | US5604121 Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 02/18/1997 | US5604118 Constructing subtracted cdna library for use in phenotypic selection of genes |
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604114 Cis-acting repression sequences, cis-acting antirepression sequences, vectors, methods of preparation and use |
| 02/18/1997 | US5604111 Conversion of oxalate to formate and carbon dioxide in presence of formyl-coa transferase together with oxalyl-coa decarboxylase |
| 02/18/1997 | US5604102 Detecting and monitoring a terminal fragment of the beta-amyloid precursor protein produced by beta-secretase cleavage; alzheimer's disease |
| 02/18/1997 | US5604101 Automated pipette penetrates sample without removal of vessel cap |
| 02/18/1997 | US5604100 Method and system for sequencing genomes |
| 02/18/1997 | US5604098 Clevage of dna at the dinucleotide sequence; cloning; labelling; genetic engineering |
| 02/18/1997 | US5604097 Methods for sorting polynucleotides using oligonucleotide tags |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/18/1997 | US5604091 Methods for protein binding enzyme complementation |
| 02/18/1997 | US5604090 Method for increasing transduction of cells by adeno-associated virus vectors |
| 02/18/1997 | US5603934 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy |
| 02/13/1997 | WO1997005488A1 Herpes simplex virus diagnostics |
| 02/13/1997 | WO1997005484A1 A method of and test kit for mutagenesis testing |
| 02/13/1997 | WO1997005286A1 ANALYSIS OF GENE EXPRESSION BY DISPLAY OF 3'-END RESTRICTION FRAGMENTS OF cDNAs |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005282A2 Methods and materials for determining relative abundance of microorganisms in mixed populations |
| 02/13/1997 | WO1997005280A1 Detection of nucleic acids and nucleic acid units |
| 02/13/1997 | WO1997005279A1 Methods of predicting the outcome of infection |
| 02/13/1997 | WO1997005278A1 Methods for determining the coat colour genotype of a pig |
| 02/13/1997 | WO1997005277A1 Nucleic acid detection method using nucleotide probes enabling both specific capture and detection |
| 02/13/1997 | WO1997005276A2 Method of sequencing by oligomer hybridisation |
| 02/13/1997 | WO1997005270A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | WO1997005268A1 Homologous recombination in mismatch repair inactivated eukaryotic cells |
| 02/13/1997 | WO1997005267A2 Mucosal delivery of polynucleotides |
| 02/13/1997 | WO1997005266A1 Methods and means for targeted gene delivery |
| 02/13/1997 | WO1997005265A1 Transport proteins and their uses |
| 02/13/1997 | WO1997005264A1 Improvements in or relating to delivery of nucleic acid |
| 02/13/1997 | WO1997005263A1 Helper virus-free herpesvirus vector packaging system |
| 02/13/1997 | WO1997005261A1 Root cortex specific gene promoter |
| 02/13/1997 | WO1997005260A2 An expression control sequence for general and effective expression of genes in plants |
| 02/13/1997 | WO1997005259A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
| 02/13/1997 | WO1997005258A2 Recombinant 60kda vegetable panallergen (co-factor-independent phosphoglycerate mutase; e.c. 5.4.2.1.) |
| 02/13/1997 | WO1997005257A1 Peptide analog inhibitors of urokinase receptor activity |
| 02/13/1997 | WO1997005256A2 Mammalian pro-hormone convertase |
| 02/13/1997 | WO1997005255A2 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | WO1997005254A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 02/13/1997 | WO1997005253A2 Transketolase-related protein |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/13/1997 | WO1997005251A2 Feline stem cell factor |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005249A2 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/13/1997 | WO1997005248A2 Solution containing chaotropic agent and process using it for isolation of dna, rna and proteins |
| 02/13/1997 | WO1997005247A1 Transgenic 'knock out' mice expressing a human apolipoprotein e |
| 02/13/1997 | WO1997005246A1 Dna strands encoding glycerol-3-phosphate acyltransferase |
| 02/13/1997 | WO1997005243A1 Gene encoding protein having asymmetric hydrolase activity on 4-substituted-1,4-dihydropyridine derivatives and expression product of the same |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005240A1 Regulated autocrine growth of mammalian cells |
| 02/13/1997 | WO1997005170A2 Broad specificity antibodies |
| 02/13/1997 | WO1997005166A1 Transforming growth factor beta crystals |
| 02/13/1997 | WO1997005165A1 Protein with plant protecting properties |
| 02/13/1997 | WO1997005164A1 Papillomavirus polyprotein constructs |
| 02/13/1997 | WO1997004862A1 Polyvinyl alcohol-based magnetic polymer particles, methods for their preparation and their use |
| 02/13/1997 | WO1997004814A1 Detecting prions in a sample and prion preparation and transgenic animal used for same |
| 02/13/1997 | WO1997004805A1 Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators |
| 02/13/1997 | WO1997004787A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | WO1997004748A2 Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
| 02/13/1997 | WO1997004647A1 Methods of detecting duplication mutated fibrillin-1 gene and compositions and methods of using the same |
| 02/13/1997 | WO1996040951A3 Use of ovary-tissue transcriptional factors |
| 02/13/1997 | WO1996040627A3 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 02/13/1997 | WO1996039528A3 MUTANT α-AMYLASE |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | WO1996034969A3 Gene therapy using replication competent targeted adenoviral vectors |
| 02/13/1997 | WO1996018732A3 Sequence-specific inhibition of dna synthesis by triplex-forming oligonucleotides |
| 02/13/1997 | WO1996017933A3 Dna encoding a cell growth inhibiting factor and its product |
| 02/13/1997 | WO1996013583A3 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 02/13/1997 | WO1996002650A3 Dna, constructs, cells and plants derived therefrom |
| 02/13/1997 | WO1995027071A3 An adenovirus supervector system |